Clinical Trial Update: A Study of BAX 888 in Male Adults With Severe Hemophilia A [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 study of BAX 888 in male adults with severe Hemophilia A have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BAX 888

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-09-11